Glicklich Alan — SEC insider filings
SEC reporting owner CIK 1823197. 10 insider filings on record with FilingPulse; latest filed 2026-10-05.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2020-10-07 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 22,391 shares, $357,432 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 20,000 shares @ $16.35 ($326,968) in CHINOOK THERAPEUTICS, INC., filed 2021-06-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. (KDNY) | Chief Medical Officer | 5 | — | 2 legs · 22,391 sh · $357,432 | 12 |
| CalciMedica, Inc. (CALC) | Director | 5 | — | — | 8 |
Insider filings — Glicklich Alan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 4 | CalciMedica, Inc. (CALC) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | CalciMedica, Inc. (CALC) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-10-14 | 4 | CalciMedica, Inc. (CALC) | Grant/award (A): 937 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | CalciMedica, Inc. (CALC) | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 4,166 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-01-16 | 4 | CalciMedica, Inc. (CALC) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-02-14 | 4 | CHINOOK THERAPEUTICS, INC. (KDNY) | Option exercise (M): 5,668 · Sale (S): 2,391 @ $12.74 · Option exercise (M): 5,668 (derivative) @ $0 | EDGAR |
| 2021-10-08 | 4 | CHINOOK THERAPEUTICS, INC. (KDNY) | Option exercise (M): 7,103 · Tax withholding (F): 2,489 @ $12.37 · Option exercise (M): 7,103 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | CHINOOK THERAPEUTICS, INC. (KDNY) | Option exercise (M): 20,000 @ $0.42 · Sale (S): 20,000 @ $16.35 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2021-02-12 | 4 | CHINOOK THERAPEUTICS, INC. (KDNY) | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 17,005 (derivative) @ $0 | EDGAR |
| 2020-10-07 | 4 | ADURO BIOTECH, INC. (KDNY) | Grant/award (A): 242,662 (derivative) · Grant/award (A): 62,660 (derivative) @ $0 · Grant/award (A): 21,311 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1823197 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs